Showing results (111-120 of 122) with videos related to
Sort By:
Pageof 13
International Journal of Cancer|July 24, 2025
Metastatic chondrosarcoma, patterns of care, and outcomes of patients in a real-life national setting over a decadeColine Ducrot, Derek Dinart, Mathilde Reich, et al.Journal of Translational Medicine|November 6, 2019
The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohortDiane Damotte, Sarah Warren, Jennifer Arrondeau, et al.American Journal of Respiratory and Critical Care Medicine|March 9, 2018
Impaired Tumor-Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD-1 BlockadeJérôme Biton, Hanane Ouakrim, Agnès Dechartres, et al.Immunity & Ageing : I & A|December 28, 2024
CD57<sup>+</sup> EMRA CD8<sup>+</sup> T cells in cancer patients over 70: associations with prior chemotherapy and response to anti-PD-1/PD-L1 therapyCécile Gonnin, Michelle Leemans, Florence Canoui-Poitrine, et al.European Journal of Cancer (Oxford, England : 1990)|February 20, 2026
Natural history and treatment sensitivity of alveolar soft part sarcoma: A national multicenter analysis from the French sarcoma groupEva Kalfala, Alexandra Meurgey, Clémence Hénon, et al.Cancer Medicine|June 3, 2026
Metastatic Ewing Sarcoma, Patterns of Care and Outcomes of Patients in a Real-Life National Setting Over a DecadeColine Ducrot, Derek Dinart, Maeva Bonneau, et al.International Journal of Cancer|September 29, 2025
Metastatic osteosarcoma, patterns of care and outcomes of patients in a real-life national setting over a decadeMathilde Reich, Derek Dinart, Hélène Bellio, et al.The Lancet. Oncology|July 10, 2023
Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trialJean-Yves Blay, Sylvie Chevret, Axel Le Cesne, et al.Journal of Cachexia, Sarcopenia and Muscle|September 14, 2021
Prevalence and prognostic impact of cachexia among older patients with cancer: a nationwide cross-sectional survey (NutriAgeCancer)Johanne Poisson, Claudia Martinez-Tapia, Damien Heitz, et al.European Radiology|August 18, 2022
Prognostic factors of the synovial sarcoma of the extremities: imaging does matterMickael Tordjman, Charles Honoré, Amandine Crombé, et al.Pageof 13